Kopran Share Price Today

United Shippers sells 12 lakh Kopran shares in open market deal

United Shippers sold 12,00,000 Kopran shares via open market on September 7, 2026. Promoter stake reduced from 4.56% to 2.07% of total voting capital. Total equity share capital of Kopran remains at 4,82,85,605 shares. Disclosure made under SEBI SAST Regulation 29(2).

Kopran declares ₹3 per share dividend, approves board changes at AGM

Kopran Limited concluded its 67th AGM on August 18, 2026, approving a ₹3 per share dividend and board changes. Shareholders passed all five ordinary resolutions, including the adoption of FY26 financial statements. The promoter group voted unanimously in favor of all items, while public non-institutional shareholders approved over 96% of votes. The meeting was conducted virtually with no qualifications in the statutory or secretarial audit reports.

Kopran net profit falls 10% to ₹670.09 lakh in Q1FY26 as margins compress

Kopran reported a 10% decline in consolidated net profit to ₹670.09 lakh for Q1FY26, driven by rising input costs that squeezed EBITDA margins to 11.55%. While consolidated earnings dipped, standalone net profit surged over 90% to ₹672.30 lakh, highlighting divergent performance between the parent entity and its subsidiaries.

Kopran Q1 Results: Net profit drops 10% YoY to ₹670 lakh

Kopran Limited's Q1FY27 results show a 10.1% YoY drop in net profit to ₹670 lakh, driven by a 34.2% revenue decline to ₹15,399 lakh. EBITDA margin contracted to 10.31%, though forex gains of ₹198 lakh provided partial relief. API segment saw growth in Carbapenems, while formulations remained reliant on African markets.

Kopran Latest Results: Consolidated Revenue ₹68,142 Lakhs, Net Profit ₹2,573 Lakhs in FY26

Kopran Limited has submitted its FY 2025-26 Annual Report along with the Notice of its 67th AGM scheduled for August 18, 2026. Consolidated revenue from operations stood at ₹68,142 lakhs with net profit of ₹2,573 lakhs, while standalone total revenue grew 11.10% to ₹30,765 lacs. The Board has recommended a final dividend of ₹3.00 per equity share, and the Panoli API facility commenced commercial production on March 31, 2026. A Scheme of Amalgamation involving Kopran Laboratories Limited with Kopran Limited is currently under regulatory review before the NCLT.

Kopran Ltd merger hearing set for Aug 5, 2026

Kopran Ltd and Kopran Laboratories Ltd will face a hearing on August 5, 2026, regarding their amalgamation scheme before the NCLT Mumbai Bench. The petition was admitted on July 1, 2026, and stakeholders must file notices of support or opposition two days prior to the hearing.